Want to see KPTI full AI Analyst Report?
Karyopharm Therapeutics (KPTI) Ownership Overview
3.66% Insiders
18.50% Mutual Funds
54.39% Other Institutional Investors
9.56% ETFs
13.89% Public Companies and
Individual Investors
The ownership structure of Karyopharm Therapeutics (KPTI) stock is a mix of institutional, retail, and individual investors. Approximately 82.45% of the company’s stock is owned by Institutional Investors, 3.66% is owned by Insiders, and 13.89% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,917,354 | Institution | 8.45% | 3,086,940 | |
| 1,125,000 | Institution | 4.96% | 1,811,250 | |
| 1,072,642 | Institution | 4.73% | 1,726,954 | |
| 876,504 | Institution | 3.86% | 1,411,171 | |
| 728,371 | Institution | 3.21% | 1,172,677 | |
| 724,211 | Institution | 3.19% | 1,165,980 | |
| 566,666 | Institution | 2.50% | 912,332 | |
| 402,887 | Institution | 1.78% | 648,648 | |
| 269,747 | Insider | 1.19% | 434,293 | |
| 175,611 | Institution | 0.77% | 282,734 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,125,000 | Institution | 4.96% | 1,811,250 | |
| 876,504 | Institution | 3.86% | 1,411,171 | |
| 724,211 | Institution | 3.19% | 1,165,980 | |
| 566,666 | Institution | 2.50% | 912,332 | |
| 402,887 | Institution | 1.78% | 648,648 | |
| 169,383 | Institution | 0.75% | 272,707 | |
| 154,213 | Institution | 0.68% | 248,283 | |
| 71,873 | Institution | 0.32% | 115,716 | |
| 43,876 | Institution | 0.19% | 70,640 | |
| 13,400 | Institution | 0.06% | 21,574 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 677,729 | Institution | 2.99% | 1,301,240 | |
| 481,328 | Institution | 2.12% | 774,938 | |
| 263,084 | Institution | 1.16% | 505,121 | |
| 175,983 | Institution | 0.78% | 283,333 | |
| 152,603 | Institution | 0.67% | 245,691 | |
| 111,503 | Institution | 0.49% | 214,086 | |
| 66,498 | Institution | 0.29% | 107,062 | |
| 42,012 | Institution | 0.19% | 44,533 | |
| 35,896 | Institution | 0.16% | 57,793 | |
| 33,962 | Institution | 0.15% | 54,679 |
FAQ
Who Owns Karyopharm Therapeutics (KPTI)?
According to the latest TipRanks data, approximately 54.39% of the company's stock is held by institutional investors, 3.66% is held by insiders, and 13.89% is held by retail investors.
What percentage of Karyopharm Therapeutics (KPTI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 54.39% of Karyopharm Therapeutics (KPTI) stock is held by institutional investors.
What percentage of Karyopharm Therapeutics (KPTI) stock is held by retail investors?
According to the latest TipRanks data, approximately 13.89% of Karyopharm Therapeutics (KPTI) stock is held by retail investors.
Who owns the most shares of Karyopharm Therapeutics (KPTI)?
Peter Kolchinsky owns the most shares of Karyopharm Therapeutics (KPTI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.